Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC5A1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | SLC5A1 |
| Aliases | Sodium/Glucose Cotransporter 1 |
| Protein Type | Transporter |
| Function | SLC5A1 serves multiple physiological functions |
| Primary Expression | the brain and may play roles in cerebral glucose metabolism relevant to neurodegenerative diseases |
| Amino Acids | 664 aa |
| UniProt ID | [P13866](https://www.uniprot.org/uniprot/P13866) |
| NCBI Gene ID | 6523 |
| GeneCards | SLC5A1 |
| Human Protein Atlas | SLC5A1 |
| Cerebral Glucose Hypometabolism | AD is characterized by reduced brain glucose utilization, and SGLT1 upregulation may represent a compensatory mechanism.[@an2018] |
| Blood-Brain Barrier | SGLT1 at the BBB may help maintain glucose supply when glucose levels are low.[@nizari2019] |
| Neuronal Vulnerability | Hippocampal neurons expressing SGLT1 may have enhanced survival during metabolic stress.[@yu2010] |
| SGLT Inhibitors | Pharmacological SGLT1 inhibition may worsen or improve AD depending on context and dosing.[@wiciski2020] |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SLC5A1["SLC5A1"]
neurodegeneration["neurodegeneration"]
SLC5A1 -->|"implicated_in"| neurodegeneration
style SLC5A1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SLC5A1 in their description or question text
No additional research found